Table 3.
CT hypoperfusion complex | |||
---|---|---|---|
Type | Sign | Definition | Incidence rate in patient with severe hypoperfusion* |
Vascular signs | Flattening of the inferior vena cava | IVC flattening with anterior-posterior diameter < 9 mm in three consecutive segments, 20 mm above and below the renal veins and at the level of the perihepatic portion | 77–100% |
The halo sign | The presence of low-density fluid < 20 HU surrounding the IVC | 77.8% | |
Small calibre aorta | A small-calibre abdominal aorta with anterior–posterior diameter < 13 mm detected 20 mm above and below the renal arteries | 20–48% | |
Visceral sign | Shock bowel | Small bowel fluid-filled dilated loops with thickened walls (> 3 mm) due to oedema of the submucosa and increased mucosal enhancement relative to the psoas muscle | 40–70% |
Mucosal enhancement of the gallbladder | Mucosal enhancement, without thickened gallbladder walls | 33.3% | |
Parenchymal signs | Peripancreatic oedema and abnormal pancreatic enhancement (shock pancreas) | Abnormal post-contrast higher attenuation than to normal density values (20 HU greater than the liver and spleen) often with peripancreatic low-density fluid (< 20 HU) | > 44% |
Splenic hypoperfusion | Extremely decreased enhancement in contrast early CT phase | 11–29.6% | |
Abnormal liver enhancement | A reduction of hepatic enhancement (25 HU less than the spleen) | 4–11.1% | |
Abnormal renal enhancement | Increased and prolonged parenchymal enhancement | 55.6% | |
Abnormal adrenal hyperenhancement (adrenal stress) | Bilateral hyperenhancement of the adrenal gland | > 60% | |
Abnormal thyroid enhancement (shock thyroid) | Heterogeneous contrast hyperenhancement, similar to a multinodular gland, with the presence of low-density fluid surrounding the thyroid (5–10 HU) | Not detected | |
Other sign | Ascites | Fluid collects in peritoneal spaces | Not detected |
*Literature data from post-traumatic hypoperfusion complex [26]